Basel, Switzerland

Michael Tamm

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Michael Tamm – A Journey in Medical Inventions

Introduction

Michael Tamm, based in Basel, Switzerland, is a notable inventor recognized for his contributions to medical science. With a focus on cardiology and respiratory health, his innovative work has led to the development of novel therapeutic approaches.

Latest Patents

Michael Tamm holds a patent for the "Use of fumaric acid derivatives for treating cardiac insufficiency and asthma." This invention encompasses a range of fumaric acid derivatives, including dialkyl fumarates and fumaric acid monoalkyl ester salts. Specifically, it addresses treatments for conditions such as left ventricular insufficiency, myocardial infarction, angina pectoris, and asthma. The patent highlights the potential of these compounds in creating effective medications for both cardiac and pulmonary diseases.

Career Highlights

Michael Tamm's professional journey is anchored at Biogen Idec International GmbH, where he dedicates his expertise to the research and development of groundbreaking medical therapies. His insights and innovative ideas have significantly impacted the field of medicine, particularly in the treatment of chronic conditions affecting the heart and lungs.

Collaborations

Collaboration is essential in innovation, and Michael Tamm has worked alongside esteemed colleagues such as Rajendra Kumar Joshi and Hans-Peter Strebel. Together, they have contributed to advancing research and bringing new inventions to the forefront of medical science.

Conclusion

Michael Tamm's work exemplifies the spirit of innovation in the medical field. His patent on fumaric acid derivatives showcases the potential for new treatments that could enhance the quality of life for those suffering from cardiac and respiratory ailments. As he continues his work at Biogen Idec International GmbH, the medical community eagerly anticipates the future advancements he and his collaborators will produce.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…